A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine:
- the safety of pemetrexed and any side effects that might be associated with it
- how much pemetrexed should be given to patients.
It is possible that information collected during this study will be analyzed by the Sponsor
in the future to evaluate pemetrexed for other possible uses or for other medical or
scientific purposes other than those currently proposed.
Although pemetrexed has been shown to be effective in some patients with non-small-cell lung
cancer, pemetrexed might not have beneficial effects for all patients.